吃奶呻吟打开双腿做受动态图 -亚洲色偷偷色噜噜狠狠99网-日韩精品极品视频在线观看免费-来一水AV@lysav

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
人妻无码中文字幕,久久久久亚洲精品无码网址
首頁 > 產(chǎn)品中心 > 標記一抗 > 產(chǎn)品信息
Rabbit Anti-MDM2 /BF350 Conjugated antibody (bs-23748R-BF350)
訂購熱線:400-901-9800
訂購郵箱:sales@xucheq.com
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@xucheq.com
說 明 書: 100ul  
100ul/2980.00元
大包裝/詢價
產(chǎn)品編號 bs-23748R-BF350
英文名稱1 Rabbit Anti-MDM2 /BF350 Conjugated antibody
中文名稱 BF350標記的雙微體2癌基因抗體
別    名 Double minute 2 protein; Hdm 2; HDM2; MDM 2; Mdm2 transformed 3T3 cell double minute 2 p53 binding protein (mouse) binding protein 104kDa; MDM2BP; Mouse Double Minute 2; MTBP; Murine Double Minute Chromosome 2; Oncoprotein Mdm2; p53 Binding Protein Mdm2; Ubiquitin protein ligase E3 Mdm2; MDM2_HUMAN; E3 ubiquitin-protein ligase Mdm2.  
規(guī)格價格 100ul/2980元 購買        大包裝/詢價
說 明 書 100ul  
研究領(lǐng)域 腫瘤  細胞凋亡  表觀遺傳學  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human, Mouse,  (predicted: Rat, Dog, Pig, )
產(chǎn)品應用 ICC=1:50-200 IF=1:50-200 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 55kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human MDM2
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹 background:
Inhibits TP53/p53- and TP73/p73-mediated cell cyclearrest and apoptosis by binding its transcriptional activation domain. Functions as a ubiquitin ligase E3, in the presence of E1 and E2, toward p53 and itself. Permits the nuclear export of p53 and targets it for proteasome-mediated proteolysis. Binds p53, p73, ARF(P14), ribosomal protein L5 and specifically to RNA. Can interact also with retinoblastoma protein(RB), E1A-associated protein EP300 and the E2F1 transcription factor. Forms a ternary complex with TP53/p53 and WWOX. Interacts with CDKN2AIP, MTBP, TRBG1 and USP7. Isoform Mdm2-F does not interact with TP53/p53. Interacts with PYHIN1. Interacts with, and ubiquitinates HIV-1 Tat. Belongs to the MDM2/MDM4 family.

Function:
E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as an ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways.

Subcellular Location:
Nucleus, nucleoplasm. Cytoplasm. Nucleus, nucleolus. Expressed predominantly in the nucleoplasm. Interaction with ARF(P14) results in the localization of both proteins to the nucleolus. The nucleolar localization signals in both ARF(P14) and MDM2 may be necessary to allow efficient nucleolar localization of both proteins. Colocalizes with RASSF1 isoform A in the nucleus.

Tissue Specificity:
Ubiquitous. Isoform Mdm2-A, isoform Mdm2-B, isoform Mdm2-C, isoform Mdm2-D, isoform Mdm2-E, isoform Mdm2-F and isoform Mdm2-G are observed in a range of cancers but absent in normal tissues.

Post-translational modifications:
Phosphorylated in response to ionizing radiation in an ATM-dependent manner.
Auto-ubiquitinated; which leads to proteasomal degradation. Deubiquitinated by USP2 leads to its accumulation and increases deubiquitinilation and degradation of p53/TP53. Deubiquitinated by USP7; leading to stabilize it.

DISEASE:
Note=Seems to be amplified in certain tumors (including soft tissue sarcomas, osteosarcomas and gliomas). A higher frequency of splice variants lacking p53 binding domain sequences was found in late-stage and high-grade ovarian and bladder carcinomas. Four of the splice variants show loss of p53 binding.

Similarity:
Belongs to the MDM2/MDM4 family.
Contains 1 RanBP2-type zinc finger.
Contains 1 RING-type zinc finger.

Database links:

Entrez Gene: 4193 Human

Entrez Gene: 17246 Mouse

Entrez Gene: 314856 Rat

Omim: 164785 Human

SwissProt: Q00987 Human

SwissProt: P23804 Mouse

Unigene: 484551 Human

Unigene: 22670 Mouse

Unigene: 447669 Mouse

Unigene: 91829 Rat



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

Mdm2基因在腫瘤發(fā)生、發(fā)展的過程中起著重要作用,Mdm2蛋白過度表達與p53基因突變有重要的關(guān)聯(lián)性。Mdm2基因在腫瘤發(fā)生、發(fā)展的過程中起著重要作用。MDM2廣泛分布于人體正常組織中,可與p53蛋白相互作用?;罨膒53導致MDM2表達,而MDM2的表達又可抑制野生型p53的轉(zhuǎn)錄激活作用。MDM2通常在軟組織肉瘤中有過表達現(xiàn)象,而在膀胱癌、乳腺癌、宮頸癌、膠質(zhì)細胞瘤中也有一定程度的表達,并可能與腫瘤細胞的耐藥有關(guān)。
版權(quán)所有 2004-2026 www.xucheq.com 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號
你懂的电影| 一本一道AV无码中文字幕| 熟妇人妻中文字幕| 亚洲乱码日产精品BD在线观看| 久久人人爽人人爽人人AV东京热| 欧洲AV无码放荡人妇网站| 熟妇人妻系列AV无码一区二区| 亚洲熟妇无码一区二区三区导航| 亚洲欧美日韩精品久久亚洲区| 亚洲av在线观看美女高潮| 俄罗斯大荫蒂女人毛茸茸| 人妻无码中文字幕| 亚VA芒果乱码一二三四区别| 亚洲中文字幕无码爆乳AV久久| 久久天天躁狠狠躁夜夜躁2014| 亚洲AV无码一区二区二三区入口| 60欧美老妇做爰视频| 成人免费ā片在线观看 | 免费看又黄又无码的网站| 顶级少妇做爰视频在线观看| 人妻人人揉人人躁人人A片| WWW国产精品内射老熟女| 中文字幕人妻女友一区蜜芽视频| 精品熟人妻一区二区三区四区不卡 | 国产精品久久午夜夜伦鲁鲁 | 一个人看的WWW片免费高清中文| 精品国产一区二区三区AV性色| 亚洲乱妇亚洲乱妇XINGLU| 妈妈的朋友2在线观看| 男男开小嫩苞好深啊H窑子开| 色多多app| 欧美激情第1页| 色欲人妻综合AAAAAAAA网| 国产美女被遭强高潮免费网站| 老熟女毛茸茸浓毛| 又大又紧又粗C欧美成人在线视频 国产精品人人做人人爽人人添 | 护士的初苞被强开了| 无码JK粉嫩小泬在线观看欧美| 日本护士毛茸茸高潮| 亚洲AV日韩AV无码污污网站 | 双胞胎(H)互攻|